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Abstract Systems biology is the creation of theoretical
and mathematical models for the study of biological sys-
tems, as an engine for hypothesis generation and to provide
context to experimental data. It is underpinned by the
collection and analysis of complex datasets from different
biological systems, including global gene, RNA, protein
and metabolite profiles. Regenerative medicine seeks to
replace or repair tissues with compromised function (for
example, through injury, deficiency or pathology), in order
to improve their functionality. In this paper, we will ad-
dress the application of systems biology approaches to the
study of regenerative medicine, with a particular focus on
approaches to study modifications to the genome, tran-
scripts and small RNAs, proteins and metabolites.
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Abbreviations
ChIP Chromatin immunoprecipitation
SDS-PAGE Sodium dodecyl sulphate polyacrylamide
gel electrophoresis
qPCR Quantitative polymerase chain reaction
Introduction
Regenerative medicine concerns the repair or replacement
of damaged, diseased or otherwise poorly functioning tis-
sues and organs, with the aim of restoring biological func-
tionality. Systems biology offers many opportunities at the
research and clinical level for the experimentation and fa-
cilitation of regenerative medicine, by providing models that
predict the effects of drugs, diseases or treatments on bio-
logical systems at multiple levels and allow the contextu-
alisation of changes, whether stoichiometrically or
quantitatively in terms of the interacting networks of genes,
transcripts, proteins, metabolites and phenotypic data. While
a basic theoretical model of a biological system may be
obtained by genome-wide reconstruction, to be relevant, it
should be refined with recourse to high-density ‘omics ap-
proaches. There are specific advantages and disadvantages
unique to each technique and –omic system of interest, but
broadly the approaches offer the production of complex, in-
depth, data-rich datasets that offer a snapshot insight into the
epigenomic, transcriptomic, proteomic or metabolomic
profile of the cells of interest at a particular point in time.
This is an important point to note, as each of these systems is
dynamic and can be modulated with time. Analysis at dif-
ferent time-points can offer some insight into the stability of
particular results over time, and systems biology often ne-
cessitates that the data are obtained at intervals over a time
series, in order to investigate the dynamics of the system of
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interest. Systems biology requires an iterative approach
whereby the models can be created, tested, refined and re-
tested, with the aim of ultimately producing models that
approximate the reality of the biological systems of interest.
In this paper, we discuss various analytical techniques that
can be used to investigate systems biology and studies that
have begun to apply this to the study of regenerative medicine.
Systems Biology: Modelling Biological Systems
Huang et al. elegantly discuss the properties of systems
biology applied to stem cell biology. The authors describe
the properties of the stem cell network in terms of its state
space (the ‘three-dimensionality’ of large numbers of in-
terconnected pathways and networks as they feed into and
affect each other, in contrast to the more linear pathway
descriptions), the high dimensionality of the system
(comprising large numbers of variables) and the hetero-
geneity of the system (to account for the discrepancy be-
tween the implicitly assumed homogeneity of tissue
cultures and the heterogeneity of actual populations) [1••].
The networks have ‘traffic’ in different directions, based
on the three-dimensionality of the integrated networks,
which can be modulated with time, to accommodate the flux
and directionality of movement in the system. This equates to
network features such as gene expression levels, protein and
metabolite abundance and post-translational modifications.
These dynamic models begin to mathematically describe the
interactions between different systems in order to ap-
proximate the reality of the systems. Steady-state models
account for the equilibrium reached when the dynamic flux in
the system tends to balance as a result of the multi-level
interactions between different factors in the system. Certain
nodes in the system account for preferred states (or ‘attractor’
states) that tend to have multiple routes that result in these
outcomes, in order to buffer the system and stabilise it against
disruptive influences. Critically, these mathematical models
require the incorporation of real-life data to adjust and im-
prove the fit of the models to the real-life situation. Figure 1
illustrates the interaction between the state space, the high
dimensionality and heterogeneity and the requirement for the
incorporation of ‘omics data into the models in order to im-
prove the accuracy of the model and its capacity for effective
prediction of particular outcomes given a particular set of
parameters or modifiers to the system, such as prediction of
the effect of a drug on the system, or the differentiation state
of a stem cell.
Epigenetic Modifications, Small RNA and Transcript
Analysis
DNA is associated with histone proteins in structures called
nucleosomes that can be moved by the DNA remodelling
machinery, enabling conformational changes in the DNA
architecture that modulate the accessibility of the gene
promoters to the transcriptional machinery. Epigenetic
histone modifications (or ‘marks’) are a ‘language’ of post-
translational modifications (principally phosphorylation,
acetylation, methylation and SUMOylation of specific
amino acids, including lysine and serine) that can con-
tribute to the repression, or facilitation, of gene expression
by altering interactions with chromatin remodelers and
affecting chromatin dynamics [2].
Epigenomics is the study of this process at the global
level, including the histone modifications, methylation
state of the DNA (which has roles in development and
some pathologies) and other architectural changes to the
chromatin. There is currently an EMBO-funded project
underway (4DCellFate) which seeks to understand the in-
teractions between different nucleosome proteins and re-
modellers across the stem cell genome. Such multi-level
systems biology approaches offer the potential for a much
more integrated vision of the pivotal fundamental pro-
cesses in regenerative medicine, such as stem cell fate
determination. Meissner et al. examined the methylation
pattern in pluripotent stem cells and differentiated cells
using a bisulphite sequencing approach, and found that the
pattern of methylation of CpG islands (CG-rich sequences
of DNA) was distinct between stem cells, stem cells under
prolonged culture in vitro and differentiated cells, which
has relevance to both fate determination and pathological
states [3]. Epigenomics is discussed further in the context
of pluripotent and induced pluripotent stem cells in [4].
To study gene transcripts at the global level, two main
approaches are commonly used, namely next-generation
sequencing (NGS) and microarrays. Microarrays are
printed arrangements of oligonucleotide probes that enable
the simultaneous comparative analysis of the abundance of
thousands of transcripts. We have previously discussed the
application of microarray analysis in the context of bio-
materials samples, including technical details about the
application of this approach, and thus this will be discussed
in more brevity in the current review [5].
Microarrays are available for examining the abundance of
transcripts and also of small untranslated RNAs. The ex-
amination of transcript abundance has the advantage that
even low-abundance samples can be studied, as the RNA can
be amplified once converted to complimentary DNA
(cDNA). Some protocols, such as the 100 ng input modifi-
cation for the Affymetrix HuGene 1.0/2.0 ST arrays, are
particularly useful for minimising sample input. Interpreta-
tion of microarray data has the caveat that the transcripts are
not necessarily being actively translated, although this can
be circumvented using a modified technique called poly-
some analysis to harvest the fraction of mRNAs which are
associated with the translational machinery (ribosomes).
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This issue does not apply to the study of small untranslated
RNAs, as these RNA species are directly functional in RNA
editing (e.g. small nucleolar RNAs, or snoRNAs) or re-
pressing the translation of other transcripts (e.g. mi-
croRNAs, or miRNAs). Small RNA arrays are available
which enable the analysis of thousands of small RNAs, but
generally focus on miRNAs. Small RNAs have been shown
to have importance in chromatin remodelling [6] and stem
cell differentiation [7], and both snoRNA and miRNA spe-
cies have been linked with the cellular response to topo-
graphically patterned surfaces, including the stem cell
response to osteogenic topographies which could be used to
pattern orthopaedic implants [8–10].
Systems biology approaches to transcriptomics seek to
capture networks of correlated gene expression, in order to
gain insight into the interaction between gene products. This
includes large-scale, pair-wise comparisons of expressed
genes, to examine which genes could be co-regulated, and
the inter-relation of different datasets from different –omic
approaches in order to refine and extend the theoretical and
mathematical models that unite the datasets.
Although the large data yield is an advantage of systems
biology, one of the challenges for the use of –omic tech-
niques for systems biology is the vast quantity of complex
data that results from it. Certain software programmes have
been developed to aid visualisation and interpretation of
results. The likely interactions between different differen-
tially abundant RNA species can be mapped using software
such as Ingenuity Pathways Analysis (http://www.
ingenuity.com), which enables a useful overview of the in-
teractions between different genes, and can also be utilised
for the analysis of some other –omic techniques, including
Fig. 1 Schematic overview of the systems biology process, illustrat-
ing the iterative cycle between prediction and experiments and
highlighting methods of data generation and integration of ‘wet’
experimental data (such as –omics data) for the refinement of the
mathematical models. Inset image illustrates part of the modelling
process, comparing the ‘topology’ of a gene network in terms of
linear pathway delineation (a more traditional biochemistry approach)
with its position within a network of interactions at a given point in
time, and shows how this can be expanded into a three-dimensional
dynamic state space model, where each of the topologies of the
network exists at a particular state (S) at a particular point in time (t1),
but that these are dynamic, and can tend towards a particular
expression profile (or ‘attractor state’) if a suitable attractive state
(such as a suitable stimulus to promote stem cell differentiation along
a particular lineage) is present. Inset image (on topology and
dynamics) reproduced from with permission from Huang [1••]
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metabolomic data. This software also enables the prediction
of likely phenotypic changes that would result from groups
of key gene up- and down-regulations, for example, pre-
dictors of various stem cell fates. This was used recently to
gather information about the predicted fate of stem cells
cultured on osteogenic micro- and nano-topographically
patterned titania substrates [9]. If certain genes are of par-
ticular interest, microarray analyses should ideally be
validated using another technique, typically quantitative
PCR (qPCR). A number of studies addressing aspects of
regenerative medicine have also used other techniques to
complement the results of microarray data, including im-
munohistochemistry, which was used by Hsiang et al. to
examine the production of inflammatory cytokines and
indicators of healing in a rat system using a model conduit
[11].
NGS is a newer approach for the analysis of DNA
(DNA-Seq), RNA (RNA-Seq) and chromatin immunopre-
cipitation (ChIP-Seq) samples. The deep sequencing ap-
proach adopted in this technique improves the accuracy of
the sequencing data, as there should be multiple ‘reads’ of
each sequence, which enhances the coverage in DNA-Seq.
For RNA-Seq, deep sequencing has the advantage that the
number of RNA species can be quantitated, which can give
an estimate of gene expression levels, which is not avail-
able from microarray data [12]. Multiple samples can be
run in a single lane, which enables efficient multiplexing,
and in the example of RNA-Seq, the RNA is converted to
cDNA (complementary DNA, which is the reverse com-
plement of the RNA sequence), fragmented and adapters
are added. Fragments are assembled into libraries and se-
quenced in short reads, which are assembled by compar-
ison to a reference genome or sequences, or by assembling
contiguous fragments in the absence of a reference. RNA-
Seq is discussed further in [13, 14]. Rabani et al. used a
combination of metabolic labelling and sequencing to
study RNA dynamics (transcription, maturation and
degradation) in murine cells, an approach which could
offer valuable insight into the dynamics of RNA species in,
for example, primary cells isolated from clinical samples,
information which could help to bridge the gap between
global transcript and protein data [15].
Compared with microarray analysis for transcriptomic
studies, NGS has the advantage that previously uncharac-
terised RNA species can be detected in RNA-Seq, and the
technique can also detect small RNA species (small RNA-
Seq), including novel small RNAs. This technique has
great potential for use in the field of regenerative medicine,
since RNA-Seq can be used with scarce samples (down to
*10 pg in some cases) and can cope with some sample
degradation, as the sequencing approach does not require
polyadenylation of transcripts, which are useful for pre-
cious samples, such as clinical material.
Using a modified RNA-Seq approach termed ribosomal
profiling, ribosomes can be isolated in order to identify the
sections of mRNA which are ‘protected’ by the ribosomes
to gain insight into the mRNA species being actively
translated into the cell. Such analyses should help to im-
prove the interconnection between different –omic data-
sets, such as transcriptomic and proteomic studies, which
can be challenging to compare. In the context of regen-
erative medicine, these approaches would be valuable for
evaluating, for example, gene expression in clinical sam-
ples using RNA-Seq, and promoter occupation by os-
teogenic transcription factors in stem cells exposed to
different stimuli to correlate with gene expression patterns
using ChIP-Seq. In addition, genome annotation provided
by NGS can be cross-referenced with data produced by
metabolomics and proteomics (techniques for the study of
the global metabolite and protein profiles, as will be dis-
cussed) to gain insight into additional metabolic networks
that had not been fully annotated. ChIP-chip is a term used
to describe the combination of ChIP experiments and mi-
croarrays, to give a more comprehensive assessment of the
binding sites in the genome, but unlike ChIP-Seq, this
approach relies on known gene sequences being present in
the array. The complexity of the data generated by NGS
can present an issue, however, as vast datasets are gener-
ated, and the software pipelines available for the analysis
and interpretation of these data are still maturing. Data
analysis for DNA-Seq and RNA-Seq experiments is dis-
cussed further in [16].
The Global Metabolite Profile
While analysis of the genome is now well established and
proteome analysis continues to develop as a technology
(now suitable for complete analysis of some moderate-sized
proteomes) [17], the analysis of biological small molecules
has lagged behind that of the other ‘omes’ until recently. The
term ‘metabolome’ to describe the complete small molecule
complement of a biological system was coined by Oliver in
1998 [18••], and the analysis of the metabolome became
known as metabolomics or metabonomics.
Metabolites are the substrates and products of the che-
mical reactions that constitute life. As such, they comprise
an enormously heterogeneous mixture of compounds and
compound classes (e.g. sugars, amino acids, lipids, organic
acids and biogenic amines). This alone leads to significant
issues with the provision of metabolomics as a true ‘omic
technology—methods ideal for the characterization of
amino acids are likely to be poor for the characterization of
steroids, for example. Despite this, most metabolomics
platforms now detect hundreds to thousands of com-
pounds, covering the majority of key biochemical
pathways.
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Careful design of experiments is absolutely critical to a
successful metabolomic analysis. Broadly, an experiment
will consist of control and treatment samples with replicate
sets for each. Treatments may, of course, be series, such as
time-courses, dose-curves or growth curves. The number of
biological replicates is dictated by two factors: the vari-
ability of the metabolites in the sample, and the minimum
fold-change expected to be detected in the samples. For
example, clinical samples are likely to be extremely vari-
able and often even small changes in metabolite concen-
tration are of interest and thus hundreds to thousands of
samples per state may be required for sufficient statistical
power. In contrast, well-defined cell culture experiments
(for example, where cells are exposed to drug treatments)
may be characterized by low variability and the effects
may be large, so a handful of replicates may be sufficient.
We have previously discussed the application of metabo-
lomics in the context of stem cell biology [19•], and in our
experience, the use of a chloroform:methanol:water ex-
traction buffer to directly harvest metabolites from cells
adhering to biomaterial surfaces, such as titanium, has been
valuable for the rapid quenching of metabolic reactions
[19•, 20]. Quick quenching is essential for minimising ‘run-
on’ metabolic reactions, and labile metabolites can be
better retained by rapid sample processing. As with all
–omic approaches, experimental consistency is important, as
small changes in conditions, such as the volume of medium
used in a cell culture experiment, or a change in the fre-
quency of media changes, introduce unwanted additional
variables and may impact upon the experimental results.
Metabolomics experiments may also be broadly char-
acterized as ‘targeted’ or ‘untargeted’. In practice, all
metabolomics experiments are in some way ‘targeted’ due
to the inability of any single system to detect every
metabolite in a system. There is a distinction, however,
between ‘targeted’ methodologies [21, 22] that rely on
detection of carefully defined panels of compounds, and
‘untargeted’ methods [23, 24••, 25] that use broad-based
detection methods to detect as many features as possible.
There are significant advantages to each method, but
briefly, targeted methodologies generally provide more
sensitive and rigorous quantitative data on a panel of de-
tected compounds while having the limitation that one fails
to detect compounds outside this panel. Untargeted meth-
ods detect many more compounds, but are more limited in
terms of confidence of identification for the detected
metabolites, and can suffer from reproducibility issues. The
method selected depends significantly on the user’s
knowledge of the system to be studied and their goals. For
example, for hypothesis-driven analysis, such as research-
ing energy metabolism [26], a targeted method may be
most appropriate, however, if systemic effects are sus-
pected, the pathway of effect is not known, or if it is
suspected that an effect may occur at multiple foci, un-
targeted methodologies may be more appropriate.
Untargeted metabolomics can also be performed in a
high-throughput manner to give greater insight into the
dynamics of the metabolome of interest, as discussed in
[27]. And although such approaches are currently generally
restricted to the study of simple organisms such as bacteria,
future adaptation of the approach for mammalian systems
would have great potential for offering insight into the
dynamics of metabolic changes in systems of interest in
regenerative medicine. To better infer the functional rela-
tionships between different metabolites in mammalian
cells, measurements of dynamic flux in the metabolome
(known as fluxomics) can be made by rapid, repeated
sampling. This flux can be modelled by ordinary differ-
ential equations (ODEs), as discussed in [28, 29]. Flux
balance analysis uses steady-state models which make the
assumption that there is no ongoing flux in metabolite
concentration in the system, and make predictions based on
the steady-state stoichiometry of the metabolites in the
metabolic networks. A useful introduction to flux balance
analysis is provided in [28, 30]. The isotope 13C can be
used to examine the flux of metabolites, by adding labelled
metabolites and tracking the proportions in which they are
converted to other intermediates.
The two most commonly used methods of collecting
metabolomic data are by mass spectrometry (MS) [23] and
nuclear magnetic resonance [31]. MS has the advantage in
sensitivity, while NMR has the benefits of higher repro-
ducibility and absolute (rather than relative) quantitation.
MS is commonly directly coupled to a separation system
although direct infusion MS has been performed in large
studies [32]. The most commonly used separation systems
are liquid (LC) [33•] or gas [34] (GC) chromatography. GC
is generally of much higher chromatographic resolution
than LC, but LC has the benefit that no derivatisation of the
sample is usually required (GC requires compounds that
can be volatilized, so many small molecules must be
chemically modified such that they vaporize on heating).
An advantage of LC–MS is the enormous variety of
separation chemistries that are available, allowing the re-
searcher to cope with the diversity of metabolites.
Reversed-phase chromatography is ideal for separating
non-polar compounds such as lipids [24••], while HILIC
chromatography is ideal for polar compounds such as
amino acids [33•]. Ion chromatography may be used for
ionic compounds such as organic acids [35]. Of course, no
separation system is functional without a detector, and
there is a huge diversity of MS equipment that may be
coupled to chromatography systems. However, they may
be broadly categorized as either useful for targeted analysis
(Paul traps, single quadrupole and triple quadrupole in-
struments), or for untargeted analysis (time-of-flight
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instruments, orbitraps and Fourier-transform ion cyclotron
resonance mass spectrometers). The latter instruments have
undergone many developments in recent years to improve
their capabilities for targeted analysis, but they still fall
short of the sensitivity of a modern triple quadrupole
instrument.
Whether one is performing a targeted or untargeted
metabolomic analysis, the process of data analysis for MS is
relatively unchanged. Data are collected in the form of pro-
prietary raw data files and then processed to obtain defined
peaks (whether detected de novo by an algorithm, or speci-
fied by the analyst at run time), which are collated across
replicate sets and compared by their area or intensity to other
replicate sets. Statistical analysis is performed and the dataset
is put into context, either mechanistically, with reference to
biochemical pathways, or in clinical studies, stratified with
respect to clinical outcomes and patient data. Several open-
source, cross-platform programmes that automate all or part
of the process are available, such as MzMine [36], XCMS
[37] and IDEOM [38]. When performing any analysis, it is
critical to have a good understanding of the raw data, the
statistics to be applied, the fundamentals of biochemistry and
the biological question to be addressed.
We previously employed a metabolic approach to in-
vestigate the metabolic profile of stem cells cultured on
osteogenic 15-nm-high titania nanopillars. This work
highlighted the change from a metabolically quiet, quies-
cent skeletal stem cell profile on planar substrates to an
‘active’ metabolic profile on substrates inducing osteogenic
differentiation. Specific metabolites involved in the os-
teogenic differentiation process were highlighted and of
particular interest were a range of amino acids and sphin-
gosine. This study agreed with other research that showed
increased metabolic demand in cells undergoing osteoge-
nesis in response to chemical stimulation [39].
In embryonic stem cells, plasticity was associated with
an increased abundance of unsaturated (C=C double bonds)
metabolites, which was reduced in differentiating cells
[40•]. Weckwerth discussed the integration of –omic data
from different sources, including NGS and metabolomic
data [41].
The Protein Dimension
Proteomics has utility in systems biology for its ability to
capture information about post-translational modifications
(such as phosphorylation and glycosylation), relative and
absolute protein quantification and information to enhance
interfacing and integration with other systems, since pro-
tein–DNA, RNA and protein–protein interactions can be
detected using proteomic approaches.
DiGE (2D-fluorescence difference gel electrophoresis) is
a technique for the two-dimensional resolution of protein
abundance. In DiGE, proteins from control and test samples
are labelled with different fluorescent CyDyes (typically
Cy3 and Cy5), and in the first dimension, isoelectric fo-
cussing is performed to separate the labelled proteins by
native charge, which utilises a high-voltage electric current
to separate proteins along immobilised pH gradient (IPG)
strips. In the second dimension, proteins are separated by
molecular weight using the technique SDS-PAGE, to pro-
duce a ‘spot map’ of resolved proteins. The spot maps are
scanned using a fluorescent scanner at suitable wavelengths
to detect both fluorophores. Using comparative spot map
analysis software such as DeCyder (GE Healthcare), the spot
maps can be analysed to gain information about the relative
abundance of various proteins between two or more condi-
tions, and by comparison with a reference gel containing a
higher protein load, this enables protein identification, by
picking spots from the 2D gels, followed by MS. This was
used to investigate protein expression levels in osteopro-
genitors, stem cells and fibroblasts [42] cultured on micro-
[42] and nanoscale [43] topographies.
Compared with traditional 2D gel electrophoresis, the
technique has the advantages of increased sensitivity (due to
the use of fluorescent CyDyes for protein labelling) and
enhanced comparability between gels, as there is the option
of including a pooled internal standard on each gel. Protein
isoforms and post-translational modifications can also be
detected using this approach. We and others have previously
discussed experimental design for DiGE experiments [44•,
45•], technical adaptations of this technique for use with
biomaterials samples [44•] and the modification of the
technique for the detection and prevention of artefacts [46].
The use of saturation labelling (a type of CyDye labelling
that aims to label all cysteine residues in the sample proteins
with dyes with maleimide chemistry) greatly increases the
sensitivity of the technique, which makes it particularly
applicable to regenerative medicine, where clinical samples
and other scarce or valuable protein sources are routinely
used. Laser capture microdissection was used to examine
protein samples from histological sections from clinical
cancer samples, and this technique could be used to capture
small amounts of tissue from retrieved implanted devices,
organoids or similar scarce sources. In addition, as discussed
in McNamara et al. [44•], sample pooling can be a valuable
means of generating additional material, and the use of re-
lated protein sources (such as protein from tissue cultures, or
comparable tissue close to an implant) can be useful in
generating sufficient material for a reference gel when the
sample source is low abundance. DiGE was used by Horrillo
et al. to investigate the differentiation of mouse embryonic
stem cells upon treatment with zebularine, an inhibitor of
cytosine methylation [47]. DiGE was used to examine the
proteome, in concert with microarray analysis to investigate
the transcript profile of the cells, and epigenetic marks were
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examined using techniques including methylation-specific
PCR, which specifically amplifies sites that have been
methylated. These techniques were utilised alongside more
traditional cell lineage evaluation approaches, such as im-
munostaining and flow cytometry. Fractionation enables the
investigation of different sub-proteomes (such as nuclear,
nucleolar or organellar compartments) by enriching for a
particular subset of the proteome. Highly abundant proteins
can also be depleted to enhance the detection of other less-
abundant proteins, for example using albumin-depletion
columns.
Some liquid chromatographic (LC)-based approaches,
where LC separation is coupled to mass spectrometric
protein identification, such as iTRAQ (isobaric tags for
relative and absolute quantification), can be used to enable
multiple comparisons between different conditions of in-
terest and can be used to produce quantitative data on
protein abundance. The ability to compare up to eight
conditions against each other (in an ‘8-plex’ experiment)
has great advantages for regenerative medicine, by en-
abling the comparison of the proteome under a variety of
conditions, for example, following culture of cells on dif-
ferent biomaterials surfaces, or under different culture
conditions. The iTRAQ approach was used to compare the
protein profile of embryonic stem cells and the equivalent
stem cells of teratocarcinomas [48].
Approaches such as stable isotopic labelling of amino
acids in cell culture (SILAC) enable the comparative
metabolic labelling of mammalian cells during culture, by
incorporating heavy and light isotopes of amino acids
during culture under two different culture conditions. This
approach is useful for in vitro tissue culture experiments
and, since the metabolic labelling is performed in living
cells, avoids issues with labelling artefacts (which can
occur with DiGE under some conditions) and changes to
the proteome that can occur during protein extraction that
could lead to the depletion of protein from one sample
group, which can occur with post-extraction labelling ap-
proaches. Dynamic SILAC is useful for collecting infor-
mation across a time series, enabling a systems biology
approach to be adopted. Sobczyk et al. examined the effect
of chemoattractants on the cytoskeleton of the slime mould
Dictyostelium over a timescale of under a minute [49•].
Dynamic SILAC has also been used to investigate global
protein turnover in human cells [50•], and pulsed SILAC
was used to investigate modulation of the proteome in re-
sponse to induction of miRNAs [51]. In the context of
regenerative medicine, such techniques have the potential
to offer valuable insight into the dynamics of the proteome
under different conditions, for example, the protein signa-
tures and biomarkers associated with cytocompatibility and
immunotolerance of materials with time.
Future Directions
In future studies, the incorporation of high-content imag-
ing, such as immunofluorescence with microscopy suited to
automated image collection, and analysis pipelines for the
extraction of multidimensional image descriptors would be
a valuable addition to systems biology studies in regen-
erative medicine. A high-content image approach was
previously used to identify a ‘signature’ of cellular features
that could be used for lineage prediction of stem cells at
early time-points [52], and such a setup would have great
potential for enhancing the predictive power of systems
biology approaches.
Conclusions
Systems biology aims to integrate data from a variety of
global data sources, including genomics, fluxomics, meta-
bolomics, proteomics, transcriptomics, epigenomics,
DNA–protein interactions and interactomics. These tech-
niques would benefit regenerative medicine as the data
yield is high and increasingly comprehensive, and systems
biology has the potential to gain more functional infor-
mation from the datasets by modelling biological systems
and enabling the prediction of states in response to defined
changes to the system. This would be invaluable for
modelling processes such as stem cell fate determination,
predicting implant tolerance or reactivity and characteris-
ing the development of organoids.
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